PG · XBRL financial data
PROCTER & GAMBLE financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (PG's year ends in late June)
| In millions of dollars | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2026 |
|---|---|---|---|---|---|---|
| Revenue | 76,118 | 80,187 | 82,006 | 84,039 | 84,284 | 87,032 |
| Cost of goods and services sold | 37,108 | 42,157 | 42,760 | 40,848 | 41,164 | 43,362 |
| Research and development | 1,900 | 2,000 | 2,000 | 2,000 | 2,100 | 2,100 |
| Selling, general and administrative | 21,024 | 20,217 | 21,112 | 23,305 | 22,669 | 23,922 |
| Operating income (loss) | 17,986 | 17,813 | 18,134 | 18,545 | 20,451 | 19,748 |
| Interest income | 45 | 51 | 307 | 473 | 469 | 430 |
| Interest expense | 502 | 439 | 756 | 925 | 907 | 877 |
| Other income (expense) | 86 | 570 | 668 | 668 | 154 | 1,076 |
| Income tax expense (benefit) | 3,263 | 3,202 | 3,615 | 3,787 | 4,102 | 4,233 |
| Net income (loss) | 14,306 | 14,742 | 14,653 | 14,879 | 15,974 | 16,046 |
| Earnings per share, basic USD per share | 5.69 | 6.00 | 6.07 | 6.18 | 6.67 | 6.75 |
| Earnings per share, diluted USD per share | 5.50 | 5.81 | 5.90 | 6.02 | 6.51 | 6.62 |
| Weighted average shares, basic millions of shares | 2,466 | 2,410 | 2,368 | 2,360 | 2,350 | 2,334 |
| Weighted average shares, diluted millions of shares | 2,601 | 2,539 | 2,484 | 2,472 | 2,454 | 2,423 |
Balance sheet
CSVFiscal years (PG's year ends in late June)
Cash flows
CSVFiscal years (PG's year ends in late June)
| In millions of dollars | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 | Jun 30, 2025 | Jun 30, 2026 |
|---|---|---|---|---|---|---|
| Net income (loss) | 14,306 | 14,742 | 14,653 | 14,879 | 15,974 | 16,046 |
| Stock-based compensation | 540 | 528 | 545 | 562 | 476 | 524 |
| Depreciation and amortization | 2,735 | 2,807 | 2,714 | 2,896 | 2,847 | 3,160 |
| Net cash from operating activities | 18,371 | 16,723 | 16,848 | 19,846 | 17,817 | 19,556 |
| Purchases of property and equipment | 2,787 | 3,156 | 3,062 | 3,322 | 3,773 | 4,409 |
| Net cash from investing activities | (2,834) | (4,424) | (3,500) | (3,504) | (3,818) | (4,624) |
| Share repurchases | 11,009 | 10,003 | 7,353 | 5,006 | 6,500 | 5,028 |
| Dividends paid | 8,263 | 8,770 | 8,999 | 9,312 | 9,872 | 10,232 |
| Proceeds from long-term debt | 4,417 | 4,385 | 3,997 | 3,197 | 2,237 | 2,652 |
| Repayments of long-term debt | 4,987 | 2,343 | 1,878 | 2,335 | 1,977 | 3,390 |
| Net cash from financing activities | (21,531) | (14,876) | (12,146) | (14,855) | (14,036) | (14,460) |
| Net change in cash | (5,893) | (3,074) | 1,032 | 1,235 | 75 | 386 |
Compare with peers
SIC 2840 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 2840 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (2840) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Procter & Gamble | 15,365 | 23,276 | 5,767 | 2.3B | — | 10-QSep 30, 2026 |
| Colgate Palmolive | 1,527 | 5,369 | 1,171* | 794.9M | — | 10-QSep 30, 2026 |
| Ecolab | 722 | 4,695 | 764* | 280.5M | — | 10-QSep 30, 2026 |
| Church & Dwightadded: same SIC | 447 | 1,602 | 380* | 236.0M | — | 10-QSep 30, 2026 |
| Stepanadded: same SIC | 98 | 692 | 29* | 22.7M | — | 10-QSep 30, 2026 |
| Bowen Acquisitionadded: same SIC | 0 | not reported | (0)* | 2.5M | 1.4 quarters | 10-QJun 30, 2026 |
| Longevity Health Holdingsadded: same SIC | 0 | 0.4 | (0.2)* | 2.5M | 0.2 quarters | 10-QJun 30, 2026 |
| Orion Blissadded: same SIC | 0 | 0 | (0) | 3.0M | — | 10-QJul 31, 2026 |
| Park Ha Biological Technologyadded: same SIC | 3.8 | year only | year only | not reported | — | 20-F/AOct 31, 2025 |
Not investment advice. Not affiliated with the U.S. SEC.
